Different Response Behavior to Therapeutic Approaches in Homozygotic Wilson’s Disease Twins with Clinical Phenotypic Variability: Case Report and Literature Review

por Samadzadeh, Sara, Kruschel, Theodor, Novak, Max, Kallenbach, Michael, Hefter, Harald
Publicado 2022

Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease

por Arslan, Max, Novak, Max, Rosenthal, Dietmar, Hartmann, Christian J., Albrecht, Philipp, Samadzadeh, Sara, Hefter, Harald
Publicado 2022

Differences in the Time Course of Recovery from Brain and Liver Dysfunction in Conventional Long-Term Treatment of Wilson Disease

por Hefter, Harald, Kruschel, Theodor S., Novak, Max, Rosenthal, Dietmar, Luedde, Tom, Meuth, Sven G., Albrecht, Philipp, Hartmann, Christian J., Samadzadeh, Sara
Publicado 2023

Pseudocholinesterase as a Biomarker for Untreated Wilson’s Disease

por Hefter, Harald, Arslan, Max, Kruschel, Theodor S., Novak, Max, Rosenthal, Dietmar, Meuth, Sven G., Albrecht, Philipp, Hartmann, Christian J., Samadzadeh, Sara
Publicado 2022